CPT Modifier 25 in Medical Billing: When to Append, Documentation Requirements, and CMS Payer Rules

CPT Modifier 25 in Medical Billing: When to Append, Documentation Requirements, and CMS Payer Rules is the definitive resource for physician practices that perform procedures and evaluation and management services on the same date of service. Modifier 25, as defined by the American Medical Association in the CPT codebook, identifies a significant, separately identifiable evaluation and management service by the same physician on the same day as a procedure or other service. Used correctly, it protects legitimate revenue. Used without adequate documentation, it is one of the fastest paths to a post-payment audit demand or a Medicare Part B refund request. MMBS (MyMedicalBillSolution.com) maintains a 98.2% clean claim rate across all specialties, compared to the industry average of 75 to 85% first-pass clean claim rates, in part because our AAPC-certified coders apply Modifier 25 only when documentation fully supports the claim.

Reviewed by Sofia Reyes, CPC, CPMA. Senior Medical Billing Specialist at MMBS. Sofia has 10+ years of experience in process design and coding compliance and holds active AAPC certification.

CPT Modifier 25 Definition: AMA Criteria, Significant E/M Service Requirements, and Three Critical Conditions

The AMA defines Modifier 25 as a significant, separately identifiable evaluation and management (E/M) service by the same physician or other qualified health care professional on the same day as a procedure or other service. Three conditions must all be true before the modifier can be appended to an E/M CPT code.

• Modifier: 25
• Modifier type: Level I (CPT) Modifier
• Category: E/M Modifiers
• AMA definition: Significant, separately identifiable evaluation and management service by the same physician on the same day as a procedure or other service
• Applied to: E/M CPT code (not the procedure code)
• Global period scope: 0-day and 10-day global procedures (same-day E/M); not applicable to 90-day major surgery pre-op E/M
• OIG risk status: High-risk billing area (annual Work Plan inclusion)
• Primary audit trigger: Usage rate statistically above specialty norm in CMS claims analytics

First, the E/M service must be significant. This means the visit must go above and beyond the work ordinarily associated with the procedure itself. A brief pre-procedure blood pressure check does not qualify. A detailed history, physical examination, and medical decision-making session addressing a separate or complicating condition does qualify.

Second, the E/M service must be separately identifiable in the medical record. The progress note must document a complete encounter, with its own assessment and plan, that stands apart from the procedure note. Sharing a single note block between the E/M and the procedure does not meet CMS (Centers for Medicare and Medicaid Services, the federal agency that administers Medicare Part B and publishes the annual Physician Fee Schedule) audit standards.

Third, both services must occur on the same date of service. Modifier 25 does not apply when the E/M visit and the procedure take place on separate days, and in that case no modifier is needed at all.

Understanding these three conditions is the starting point for a defensible specialty coding compliance protocol involving Modifier 25.

Same-Day E/M and Procedure Billing: Correct CPT Code Pairs, ICD-10 Coding Strategy, and Claim Line Placement

Modifier 25 is always appended to the E/M CPT code, never to the procedure code. The procedure is billed on a separate claim line without a modifier. Below are three correct billing scenarios that illustrate real-world application.

Scenario one: A dermatologist performs an annual skin examination (CPT 99213, established patient office visit, 2024 CMS average reimbursement $77.74 under the Medicare Physician Fee Schedule), identifies a suspicious lesion, and performs a skin biopsy (CPT 11102, tangential biopsy of skin, CMS average $116.54). The E/M note documents the full skin examination with medical decision-making on the biopsy indication. The correct claim is CPT 99213-25 on line one, CPT 11102 on line two. The ICD-10 code for the suspicious lesion (for example, D23.9, other benign neoplasm of skin, unspecified) should appear on both lines.

Scenario two: A family physician sees a patient for a diabetes follow-up (CPT 99214, established patient office visit, CMS average $109.97) and removes cerumen (CPT 69210, removal of impacted cerumen, CMS average $52.03) during the same encounter. The E/M note documents the diabetes management discussion separately from the cerumen removal procedure note. Correct billing is CPT 99214-25 plus CPT 69210. The diabetes ICD-10 code (ICD-10 E11.9, type 2 diabetes mellitus without complications) applies to the E/M line; the cerumen ICD-10 code applies to the procedure line.

Scenario three: An orthopedist evaluates knee pain (CPT 99213), documents the examination and shared decision-making regarding a corticosteroid injection, and then administers the injection (CPT 20610, arthrocentesis, aspiration, or injection of major joint). The correct billing is CPT 99213-25 and CPT 20610. The ICD-10 code for the knee pain (for example, M25.561, pain in right knee) should appear on both lines. Using the same ICD-10 code on both lines is acceptable for Medicare in this context, but some commercial payers flag it. See the payer-specific section below for guidance on UnitedHealthcare's editing policy.

For additional guidance on high-frequency E/M codes that commonly appear with Modifier 25, see our 99213 documentation and reimbursement guide and 99214 medical decision-making reference.

CMS Global Surgical Package Rule: 0-Day, 10-Day, and 90-Day Global Periods and How They Affect Modifier 25 Billing

CMS assigns every procedure a global surgical period of 0, 10, or 90 days. The global period defines which related services are bundled into the procedure reimbursement and cannot be separately billed.

For procedures with a 0-day global period (the majority of minor office procedures including injections and most biopsies), CMS allows a separate E/M on the day of the procedure if Modifier 25 is appended and the documentation shows a significant, separately identifiable service. This is the most common Modifier 25 scenario and the one with the most CMS scrutiny.

For procedures with a 10-day global period (some minor surgeries), the same rule applies on the day of surgery: a separate E/M is allowed only with Modifier 25 and adequate documentation. During the 10 post-operative days, unrelated E/M services require Modifier 24, not Modifier 25.

For procedures with a 90-day global period (major surgeries), a pre-operative E/M on the day of surgery is generally not separately payable regardless of modifiers, unless it addresses a completely unrelated condition. Some practices attempt to use Modifier 25 on major surgery dates and then receive CMS post-payment audit demand letters. Verify the global period for every procedure code your practice performs and incorporate that logic into your claim submission workflow within your EHR (Electronic Health Record) system.

MMBS integrates global period lookups into our upstream claims-management process before every claim leaves the queue, catching these errors at the source.

Payer-Specific Modifier 25 Policies: Medicare Part B, Aetna, UnitedHealthcare, and BCBS Coverage Determination Rules

Modifier 25 rules are not uniform. Each payer maintains its own coverage policy, and billing teams that assume Medicare rules apply everywhere will encounter denials and audit exposure.

Medicare Part B follows the CMS Claims Processing Manual, Chapter 12, Section 30.6.1. CMS allows Modifier 25 even when the E/M and the procedure relate to the same diagnosis, provided the E/M is significant and separately identifiable. Medicare Administrative Contractors (MACs) conduct post-payment audits targeting Modifier 25 claims and will issue demand letters for refunds when documentation does not support the modifier. Practices can verify specific MAC policies through the Medicare fee schedule and coverage portal for their region.

Aetna's medical policy on Modifier 25 requires that the E/M reflect a significant amount of additional work above the pre-procedure evaluation. Aetna requests records on Modifier 25 claims at elevated rates for high-volume proceduralists. Templated notes without individualized assessment and plan language carry higher audit risk. Practices billing Aetna should review Aetna's Clinical Policy Bulletins relevant to their specialty before establishing a Modifier 25 workflow.

UnitedHealthcare (UHC) applies claim editing software under its Claim Editing Policy that can automatically downcode or deny the E/M service if identical ICD-10 diagnosis codes appear on both the E/M line and the procedure line without a supporting narrative showing separately identifiable work. Using a distinct ICD-10 code for the E/M problem (when a distinct condition is being addressed) is the cleanest approach for UHC claims. When the same diagnosis applies to both services, the progress note must contain clear narrative evidence of separately identifiable work to withstand UHC's editing logic. Our UHC prior authorization and billing checklist outlines the documentation standards required before submission.

BCBS (Blue Cross Blue Shield) plans vary by state but generally follow Medicare guidelines. BCBS Federal Employee Program mirrors CMS closely. Some state BCBS plans apply additional specialty-specific criteria. Always check the applicable local coverage determination or BCBS medical policy before treating CMS rules as universal.

Cigna and Humana both maintain Modifier 25 policies available in their provider portals. Cigna's editing logic is similar to UHC's and may flag claims where the E/M and procedure share a single diagnosis code without a separate problem notation in the medical record. Proactive verification against these policies, built into a structured revenue cycle workflow, reduces denial rates before claims reach the payer.

Modifier 25 Documentation Requirements: E/M Note Components, 2021 AMA Guidelines, and Medical Decision-Making Standards

Inadequate documentation is the single most common reason Modifier 25 claims fail audit. Under the 2021 AMA E/M coding guidelines (which CMS adopted for Medicare Part B), the documentation requirements for office and outpatient E/M services shifted away from point-counting of history and exam elements toward medically appropriate history, examination, and medical decision-making (MDM).

For a Modifier 25 claim, the progress note must contain all of the following to withstand CMS or commercial payer audit review.

A medically appropriate history addressing the presenting problem for the E/M service. This does not have to be a comprehensive review of systems, but it must clearly relate to the condition being evaluated during the E/M encounter, not to the procedure indication alone.

A medically appropriate physical examination relevant to the E/M problem. The 2021 guidelines allow documentation to focus on what is clinically relevant, but the exam must be recorded as a distinct section of the note, separate from any procedure prep or post-procedure note.

Medical decision-making or total time documentation that stands independently from the procedure note. The MDM section must show the provider's assessment of the problem's complexity, the data reviewed, and the management decisions made for the E/M problem. A procedure note that simply describes what was done does not substitute for MDM on the E/M service.

A separate assessment and plan section addressing the E/M problem. If an auditor reads the note and cannot identify a clearly distinct E/M assessment apart from the procedure rationale, the modifier will not withstand scrutiny under either CMS guidelines or commercial payer standards.

HIPAA (Health Insurance Portability and Accountability Act, governed by 45 CFR Parts 160 and 164) requires all medical billing companies, including MMBS, to operate as signed Business Associates (BAAs) with each practice client. This means MMBS handles PHI in full compliance with HIPAA standards during chart audits and documentation review, with no data stored outside of HIPAA-compliant systems. Practices using our HIPAA-compliant billing and audit services receive documentation compliance reviews as part of the denial prevention workflow.

Modifier 25 Audit Risk Management: OIG High-Risk Billing List, Statistical Benchmarks, and Self-Audit Protocol

Modifier 25 has appeared on the Office of Inspector General (OIG) Work Plan as a high-risk billing practice for several consecutive years. Both CMS and commercial payers use claims analytics to identify providers whose Modifier 25 usage rate is statistically above specialty norms. If your practice bills Modifier 25 on 80% of procedure-day encounters but specialty benchmarks from CMS data show 30% to 40%, your practice is a statistical outlier and a likely candidate for a focused audit.

A practical self-audit protocol reduces this risk. Pull 20 to 30 claims per quarter where Modifier 25 was used. For each claim, ask: does the progress note clearly show a significant, separately identifiable E/M service? Does the assessment and plan section address a distinct problem? Is the medical decision-making documented independently from the procedure rationale? If the answer is no on more than a small portion of the sample, that finding represents a documentation and training workflow issue that should be corrected before an outside auditor identifies it.

Practices should also monitor their EOB (Explanation of Benefits) and ERA (Electronic Remittance Advice) data for Modifier 25 denial patterns. An increase in CARC (Claim Adjustment Reason Code) CO-4 (the procedure code is inconsistent with the modifier) or CO-97 (the benefit for this service is included in the allowance for another service) on Modifier 25 claims is an early indicator of a systematic documentation or coding issue. Our CO-4 denial appeal steps and CO-97 recoupment defense guide walk through the full appeal process for each code.

How MMBS Handles Modifier 25 Compliance: Pre-Audit Chart Review, Appeals Management, and NPI-Level Reporting

MMBS delivers Modifier 25 compliance as a built-in component of our end-to-end billing services rather than as a separate add-on. Every practice onboarded to MMBS receives a specialty-specific Modifier 25 benchmark report showing their usage rate against CMS and payer norms. Practices above benchmark thresholds receive a 30-chart pre-audit chart review with written findings before any payer audit is initiated.

When a Modifier 25 denial arrives via ERA, our billing team reviews the EOB remittance code, retrieves the supporting documentation from the EHR integration, and files a first-level appeal within the payer's timely filing window. Appeals include the complete progress note, the relevant CPT code description from the AMA CPT codebook, the applicable CMS Claims Processing Manual citation, and a written narrative explaining why the documentation meets the significant, separately identifiable standard.

NPI (National Provider Identifier) level reporting allows MMBS to track Modifier 25 claim outcomes by individual provider, identifying which providers have the highest appeal success rates and which need additional documentation coaching. Our AAPC-certified billing team (holding CPC and CPMA credentials issued by the American Academy of Professional Coders) achieves a first-pass denial resolution rate of 85% on appealable Modifier 25 claims and reduces average accounts receivable (AR) days to 28 to 32, compared to the industry average of 45 to 55 AR days. Prior authorization verification for procedures commonly billed alongside E/M services is also included in the pre-submission workflow, reducing the separate category of denials related to missing auth on procedure codes.

Practices billing primary care, dermatology, orthopedics, or any other procedural specialty can learn how MMBS manages Modifier 25 compliance at scale through our outsourced billing for procedural practices overview page.

Frequently Asked Questions

What does CPT Modifier 25 mean in medical billing and when is it required?

CPT Modifier 25 identifies a significant, separately identifiable evaluation and management (E/M) service performed by the same physician on the same day as a procedure or other service, as defined by the AMA CPT codebook. It is required when a provider performs both an E/M visit and a procedure during the same encounter and the E/M service is above and beyond the work typically associated with the procedure. The modifier is appended to the E/M CPT code, not the procedure code. MMBS trains all AAPC-certified coders to verify three conditions before applying Modifier 25: the E/M is significant, it is separately identifiable in the medical record, and it occurred on the same date of service as the procedure.

Can Modifier 25 be used when the E/M and the procedure address the same diagnosis?

Yes, under CMS guidelines for Medicare Part B, Modifier 25 can be appropriate even when the E/M service and the procedure relate to the same condition or ICD-10 diagnosis code, provided the E/M is significant and separately identifiable in the documentation. However, several commercial payers, including UnitedHealthcare, apply claim editing logic that may flag or deny claims where the same ICD-10 code appears on both the E/M and procedure lines without clear narrative evidence of separately identifiable work. Using a distinct ICD-10 code for the E/M problem when a distinct condition exists is the safest approach for commercial payer claim submission.

What documentation is required to support a Modifier 25 claim under 2021 AMA E/M guidelines?

Under the 2021 AMA E/M coding guidelines, which CMS adopted for Medicare Part B office and outpatient visits, the progress note for a Modifier 25 claim must include a medically appropriate history addressing the E/M problem, a medically appropriate physical examination, medical decision-making that stands independently from the procedure note, and a separate assessment and plan section for the E/M problem. Comprehensive history and exam element counts are no longer required, but the documentation must clearly show a distinct E/M encounter separate from the procedure rationale. Inadequate documentation is the most common reason Modifier 25 claims fail post-payment audit under CMS or commercial payer review.

How do Medicare Part B global surgical package rules affect Modifier 25 billing?

CMS assigns every procedure a global surgical period of 0, 10, or 90 days. For procedures with a 0-day or 10-day global period, Medicare Part B allows a separately billed E/M on the day of the procedure when Modifier 25 is appended and documentation supports the service. For procedures with a 90-day global period, a pre-operative E/M on the day of surgery is generally not separately payable unless it addresses a completely unrelated condition. Practices billing surgical specialties must verify the global period for every procedure code and incorporate that logic into their claim submission workflow within the EHR system before submitting to Medicare or any other payer.

What denial codes appear on incorrectly billed Modifier 25 claims and how should they be appealed?

The most common CARC codes on Modifier 25 denials are CO-4 (the procedure code is inconsistent with the modifier), CO-97 (the benefit for this service is included in the allowance for another service or procedure), and CO-50 (the service is not covered because it is not medically necessary). Appeals should include the complete progress note, the applicable AMA CPT modifier definition, the CMS Claims Processing Manual Chapter 12 Section 30.6.1 citation for Medicare claims, and a written narrative explaining why the documentation meets the significant, separately identifiable E/M standard. MMBS achieves an 85% first-pass resolution rate on appealable Modifier 25 denials by submitting complete appeal packages within payer timely filing windows.

How often should a practice self-audit its Modifier 25 claims to reduce audit risk?

CMS and commercial payers use claims analytics to identify providers whose Modifier 25 usage rate is statistically above specialty norms. The OIG includes Modifier 25 on its annual Work Plan as a high-risk billing area. Practices should conduct a self-audit of Modifier 25 claims quarterly, pulling 20 to 30 charts and verifying that each note contains a significant, separately identifiable E/M service with its own assessment and plan. An increase in CO-4 or CO-97 denial codes on ERA remittances is an early warning sign that documentation workflows need correction. MMBS provides NPI-level Modifier 25 usage reporting to all client practices as part of standard AR management, keeping AR days in the 28 to 32 day range that signals a healthy revenue cycle.

If your practice regularly bills procedures alongside E/M visits and you want to verify your Modifier 25 compliance is audit-ready, contact MMBS for a no-obligation coding compliance review. Our AAPC-certified billing team reviews your claims data, benchmarks your usage rate against CMS specialty norms, and delivers a written report with actionable documentation improvements. Reach out through our billing compliance review request page to get started.